(Q42254976)

19 October 2017

title

Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias (English)

1 reference

19 October 2017

1 reference

H L Greene

1

1 reference

19 October 2017

E L Graham

2

1 reference

19 October 2017

J A Werner

3

1 reference

19 October 2017

G K Sears

4

1 reference

19 October 2017

B W Gross

5

1 reference

19 October 2017

J P Gorham

6

1 reference

19 October 2017

P J Kudenchuk

7

1 reference

19 October 2017

G B Trobaugh

8

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 December 1983

1 reference

Journal of the American College of Cardiology

19 October 2017

published in

1 reference

19 October 2017

volume

2

1 reference

19 October 2017

issue

6

1 reference

19 October 2017

page(s)

1114-1128

1 reference

Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation.

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980338-6

7 January 2021

Amiodarone for control of sustained ventricular tachyarrhythmia: clinical and electrophysiologic effects in 51 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980338-6

7 January 2021

Control of refractory life-threatening ventricular tachyarrhythmias by amiodarone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980338-6

7 January 2021

Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980338-6

7 January 2021

Long-term management of sustained, recurrent, symptomatic ventricular tachycardia with amiodarone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980338-6

7 January 2021

Clinical efficacy of amiodarone as an antiarrhythmic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980338-6

7 January 2021

Clinical antiarrhythmic effects of amiodarone in patients with resistant paroxysmal tachycardias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980338-6

7 January 2021

Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980338-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980338-6

1 reference

7 January 2021

Amiodarone--benefits and risks in perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980338-6

7 January 2021

Side effects of long-term amiodarone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980338-6

7 January 2021

Amiodarone keratopathy: drug-induced lipid storage disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980338-6

7 January 2021

Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxin, and thyrotropin. A drug influencing peripheral metabolism of thyroid hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980338-6

7 January 2021

Pneumonitis and pulmonary fibrosis associated with amiodarone treatment: a possible complication of a new antiarrhythmic drug

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980338-6

7 January 2021

Amiodarone pulmonary toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980338-6

7 January 2021

Possible association of pneumonitis with amiodarone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980338-6

7 January 2021

Letter: Amiodarone and neurological side-effects

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980338-6

7 January 2021

Disparity between the clinical and electrophysiologic effects of amiodarone in the treatment of recurrent ventricular tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980338-6

7 January 2021

Amiodarone increases plasma digoxin concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980338-6

7 January 2021

The potentiation of warfarin anticoagulation by amiodarone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980338-6

7 January 2021

Interaction between warfarin sodium and amiodarone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980338-6

7 January 2021

Dangers of amiodarone and anticoagulant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980338-6

7 January 2021

Possible amiodarone-aprindine interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980338-6

7 January 2021

Dangerous interaction between amiodarone and quinidine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980338-6

7 January 2021

Intravenous amiodarone in the acute treatment of recurrent symptomatic ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980338-6

7 January 2021

Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980338-6

7 January 2021

Amiodarone-induced polymorphous ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980338-6

7 January 2021

Atypical ventricular tachycardia (torsade de pointes) induced by amiodarone: arrhythmia previously induced by quinidine and disopyramide

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980338-6

7 January 2021

Ventricular flutter during treatment with amiodarone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980338-6

7 January 2021

Amiodarone-induced ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980338-6

7 January 2021

Amiodarone in refractory life-threatening ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980338-6

7 January 2021

10.1016/S0735-1097(83)80338-6

Identifiers

DOI

1 reference

19 October 2017

1 reference